Navigation Links
Abbott's XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
Date:10/22/2007

One-year Data Demonstrate Continued Safety, Consistently Positive Clinical

Results with XIENCE V

WASHINGTON, Oct. 22 /PRNewswire-FirstCall/ -- Data presented today from Abbott's SPIRIT III U.S. pivotal clinical trial demonstrated continued positive, statistically significant clinical results for the XIENCE(TM) V Everolimus Eluting Coronary Stent System at one year, including continued clinical superiority in major adverse cardiac events (MACE) and continued non- inferior rates of target vessel failure (TVF) with XIENCE V compared to the TAXUS(R) Paclitaxel-Eluting Coronary Stent System. The results were presented at the Cardiovascular Research Foundation's 19th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium in Washington D.C.

These results follow the data presented earlier this year at the annual American College of Cardiology conference, wherein XIENCE V demonstrated superiority to TAXUS in the SPIRIT III trial on the study's primary endpoint of in-segment late loss at eight months with a statistically significant 50 percent reduction in late loss compared to TAXUS. (In-segment late loss is a measure of vessel renarrowing).

The SPIRIT III clinical trial of 1,002 patients demonstrated the following key results for XIENCE V at one year:

-- In an analysis of major adverse cardiac events (MACE), XIENCE V

demonstrated clinical superiority to TAXUS with a statistically

significant 43 percent reduction in MACE compared to TAXUS at one year.

These MACE results are consistent with the clinically superior 44

percent reduction in MACE observed for XIENCE V at nine months. MACE is

an important clinical measure of safety and efficacy outcomes for

patients, defined as cardiac death, heart attack (myocardial infarction

or MI), or ischemia-driven target lesion revascularization (TLR driven

by lack of blood supply).

--
'/>"/>

SOURCE Abbott
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Abbott Announces Continued Positive Results with Xience V Everolimus Eluting Coronary Stent in Spirit Clinical Trials
2. Abbotts Xience V Everolimus Eluting Coronary Stent Superior to Taxus Stent in Spirit III U.S. Pivotal Clinical Trial
3. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
4. Efficacy of OrbusNeichs Genous Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents
5. Abbott Announces Positive Nine-Month Results From the Worlds First Clinical Trial of a Fully Bioabsorbable Drug Eluting Coronary Stent
6. Investigators Report COSTAR II Pivotal Drug-Eluting Stent Trial Results at EuroPCR 2007
7. SPIRIT Clinical Data Reaffirm Strength of Taxus and Promus Drug-Eluting Coronary Stent Systems
8. Medtronic Announces Positive Nine-Month Results for Endeavor Resolute Next Generation Drug-Eluting Stent at EuroPCR
9. Taxus VI Clinical Trial Demonstrates Positive Long-Term Outcomes for Moderate-Release Paclitaxel-Eluting Stent at Four Years
10. ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
11. Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to Bypass Surgery and Better Outcomes Than Bare Metal Stents in Subgroup Analysis of Diabetic Patients With Multivessel Coronary Disease

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)..., , IRVINE, Calif., Nov. 24 /PRNewswire-F...eloper of minimally invasive treatments for aortic...tion to stay, or discontinue all proceedings in, t...in October 2009 by Cook, Inc. The motion was file...lis, Indiana. ,, Endologix has requested that t...
(Date:11/24/2009)..., , FREMONT, Calif., Nov. 24 /PRNewswire-...: VRMLQ) announced the Company filed its Plan of R...mber 24, 2009, with the United States Bankruptcy C...nsider approval of the Disclosure Statement is pre...aring on the confirmation of the Plan scheduled fo...
(Date:11/24/2009)..., , WOODCLIFF LAKE, N.J. and NEW YORK, ...c announced today that the U.S. Food and Drug Admi...ew Drug Application (NDA) for once daily 23 mg Ari...s for the treatment of moderate to severe Alzheime...n contains 23 mg of donepezil HCl in an extended r...
Breaking Medicine Technology:Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Vermillion Files Plan of Reorganization 2Vermillion Files Plan of Reorganization 3Vermillion Files Plan of Reorganization 4FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Las Vegas Plastic Surgery Center 28imagepluslasvegas com 29 Specializes in Non Surgical Cosmetic Procedures 60200 1Las Vegas Plastic Surgery Center 28imagepluslasvegas com 29 Specializes in Non Surgical Cosmetic Procedures 60200 2Antipsychotic Medications Cause Substantial Weight Gain in Children and Adolescents According to Scientists at the Feinstein Institute for Medical Re 60196 1Antipsychotic Medications Cause Substantial Weight Gain in Children and Adolescents According to Scientists at the Feinstein Institute for Medical Re 60196 2Antipsychotic Medications Cause Substantial Weight Gain in Children and Adolescents According to Scientists at the Feinstein Institute for Medical Re 60196 3Antipsychotic Medications Cause Substantial Weight Gain in Children and Adolescents According to Scientists at the Feinstein Institute for Medical Re 60196 4Antipsychotic Medications Cause Substantial Weight Gain in Children and Adolescents According to Scientists at the Feinstein Institute for Medical Re 60196 5Nashboro Village Family Dental to Present First Annual Super Talent and All Star Show 60191 1Nashboro Village Family Dental to Present First Annual Super Talent and All Star Show 60191 2Nashboro Village Family Dental to Present First Annual Super Talent and All Star Show 60191 3
... ACCESS PHARMACEUTICALS, INC.,(OTC Bulletin Board:...s,scheduled a conference call for March 13, 2008 a...about the status of its clinical trial programs as...parties may participate in the call by dialing (87...ate by dialing (201),689-8349 about 5-10 minutes p...
...March 10 PARI,s LC STAR nebulizer and,PRONEB Ultr... for Inspire,Pharmaceuticals, (Nasdaq: ISPH ) sec...tic fibrosis treatment. PARI reusable nebulizers a...s and are recommended in,commercial sales includin...enex and Brovana, Novartis, TOBI, Genentech,s Pulm...
Other Medicine Technology:Access Pharmaceuticals to Conduct Conference Call to Update Financial Community 2PARI Nebulizer & Compressor Used Exclusively in Inspire's Phase 3 CF Trial 2
(Date:11/26/2009)...igger thrill when on an emotional rollercoaster, s...Day News) -- Call it the fear factor meets the jub...pectators -- especially those who root for the win...,s a closely contested match and victory was in do... , Chew on that this Thanksgiving weekend as yo...
(Date:11/26/2009)... Dr. David Kim of the Live Life Again...in Dallas , is one of a growing number of physicia...working sites to connect with individuals who are ...ght morbid obesity. Dr. Kim is utilizing Facebook ...bout his practice with the community. , ...
(Date:11/26/2009)... Benton Communications announces a hi...system for retailers struggling to make an economi...ember 26, 2009 -- Flu fears is the type of challen...rgency room, according to Dr. David Benton, busine...business growth system – The Rfactor Intens...
(Date:11/25/2009)...EDINA, Minn., Nov. 25 W...f their dentist. But a chiropractor can also give...emporal-Mandibular Joint, which is where your jaw ...oral bone). ,, The most common symptoms associ...licking or popping of the jaw. But many other sym...
(Date:11/25/2009)..., EMERYVILLE, Calif., Nov. 25 /PRNewswire-FirstCal...) today announced that the company will host two i... ,, December 7, 2009 - 9:00 a.m. CT/10:00 a.... data presentations surrounding carfilzomib in rel...red at the 51st American Society of Hematology (AS...
Breaking Medicine News(10 mins):Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2
...NEAPOLIS, March 5 MinuteClinic, the pioneer and,l...d States, announced that,the company will open its...,health care centers. These locations will open at...remark,Corporation, is continuing to develop a nat...
...: BMR, TORONTO, March 5 /PRNewswire-FirstCall/ - ...ompany dedicated to the development and,commercial... end fiscal,results for 2007 on March 12, 2008, at...f Executive Officer and Mr.,Paul Van Damme, Chief ...
...HINGTON, March 5 The Tobacco-Free Kids,Action Fun... campaign,urging key Pennsylvania lawmakers to sto... that applies to all workplaces and protects all,P...s of six key legislators with a warning to,readers...
...HVILLE, Tenn., March 5 People faced with,too many...ve difficulty,discerning the right choice, they of...c theory, according to research by Vanderbilt econ...resulting,bad decisions come at a high cost to soc...
...reakout Session Leverages Personal Health Care Uti...d Decision Making and Communication -, MARLBOROU...or vice president and general manager of ...ill be a featured presenter in the "Getting Person...
... On It! Fortified Juice Beverages for Kids Introdu...ps Nationwide, ATLANTA, March 5 White Hat Brands...announced today that it has teamed up with the,Ame... children through the camp experience., "Our supp...
Other Medicine News:Health News:MinuteClinic Hits 500th Clinic Mark; New Locations Open in Dallas, Los Angeles and Orlando CVS/pharmacy Stores 2Health News:MinuteClinic Hits 500th Clinic Mark; New Locations Open in Dallas, Los Angeles and Orlando CVS/pharmacy Stores 3Health News:Notice of Bradmer Pharmaceuticals Conference Call 2Health News:Ad Campaign Urges Pennsylvania Lawmakers to Stop Waffling and Pass Comprehensive Smoke-Free Law 2Health News:Ad Campaign Urges Pennsylvania Lawmakers to Stop Waffling and Pass Comprehensive Smoke-Free Law 3Health News:NIH-funded Vanderbilt Research Seeks Ways to Avoid Information Overload in Health Care Choices Among Seniors 2Health News:Upcoming Business Health Agenda 2008 Features Workscape Executive 2Health News:White Hat Brands, American Camp Association Launch Partnership to Advance Children's Wellness 2
Fast-Cath Guiding Introducers
Ultimum Introducers
EPT-DX Steerable Diagnostic Catheters
Hydrodissection Cannula
Medicine Products: